Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Estrella Immunopharma (ESLAW) Q4 2025 Earnings
ESLAW
12
Nov
Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.19
-0.15
-0.11
-0.07
Details
Expected EPS
-0.1865
Actual EPS
-0.19
Surprise EPS
-0
Surprise Percent
+1.88%
Description
Estrella Immunopharma (ESLAW) has reported earnings of -0.19 per share for Q4 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login